Avacta Appoints Covid-19 Rapid Antigen Test Manufacturing Partner
Avacta Group has appointed BBI Solutions to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva.
Read MorePosted by Melanie Hamilton-Basich | Aug 7, 2020 | Company News, Covid 19, Immunoassay Reagents & test Kits |
Avacta Group has appointed BBI Solutions to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva.
Read MorePosted by Laurie Bonner | Jul 16, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The partnership is to evaluate the use of Affimer reagents to detect the coronavirus using novel sensors.
Read MorePosted by Laurie Bonner | Jun 11, 2020 | Covid 19 |
Highly specific bead-assisted mass spectrometry test detects the covid-19 virus spike protein at clinically relevant concentrations.
Read MorePosted by Laurie Bonner | May 14, 2020 | Covid 19, Uncategorized |
The companies are working to develop a high-throughput covid-19 antigen test using Adeptrix’s proprietary bead-assisted mass spectrometry platform.
Read MorePosted by | Apr 28, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Kidney Disease, Mass Spectrometry Reagents & Test Kits |
Multiple highly specific binders have been generated that bind to the spike proteins of SARS-CoV-2 and do not crossreact with other closely related viruses.
Read More